alexa
Reach Us +441474556909
Multiple sclerosis (MS) Medications | List of High Impact Articles | PPts | Journals | Videos
ISSN: 2376-0389

Journal of Multiple Sclerosis
Open Access

Multiple sclerosis (MS) Medications

Search results for
Multiple sclerosis (MS) Medications

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Relevant Topics

Multiple sclerosis (MS) Medications

There is no cure for multiple sclerosis. Treatment typically focuses on speeding recovery from attacks, slowing the progression of the disease and managing symptoms. Relapsing-remitting MS has certain medications which can lower the relapse rate and also formation of new lesions in early disease course. But no therapies have shown benefit for slowing the progression of primary-progressive MS. Certain disease-modifying drugs have been shown to reduce exacerbations and slow the progression of MS. Of which (Interferon drugs and Copaxone) are considered to be very safe. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under research.

Related Multiple Sclerosis Medications

Brain Disorders Journal, Neuroinfectious Diseases, Neurological Disorders Journal, NeurologyJournal, Neurophysiology Journal, Neurosciences Journal,Multiple Sclerosis, Multiple Sclerosis and Related Disorders, Consortium of Multiple Sclerosis Centers (CMSC), Therapeutic Advances in Neurological Disorders, CNS and Neurological Disorders - Drug Targets, Current Drug Targets: CNS and Neurological Disorders

Multiple sclerosis (MS) Medications

Expert PPTs

Speaker PPTs

High Impact List of Articles
Conference Proceedings